French company EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market has secured a third round of funding amounting to ten million euros ($13 million). Bernard Chauvin, a private investor, has taken an equity stake in the company alongside Omnes Capital (formerly Credit Agricole Private Equity) and the Lyon-based insurer SHAM.

arGEN-X BV has granted a worldwide exclusive license to RuiYi to develop and commercialize ARGX-109, a novel anti-IL-6 monoclonal antibody discovered and developed by arGEN-X. arGEN-X is backed by OrbiMed Advisors, Seventure Partners, Forbion Capital Partners, Credit Agricole Private Equity, LSP, BioGeneration Ventures, the Erasmus Biomedical Fund, Thuja Capital and VIB.

Coller Capital has acquired Crédit Agricole Private Equity (CAPE) and all of the funds managed by CAPE and owned by Crédit Agricole Capital Investment Finance (CACIF), a wholly-owned subsidiary of Crédit Agricole S.A. Crédit Agricole S.A.’s decision to sell CAPE forms part of a plan to optimise capital allocation and refocus the bank’s private equity [...]

arGEN-X, a biopharmaceutical company developing human monoclonal antibodies, has raised 27.5 million euro ($37 million) in Series B financing. OrbiMed Advisors and Seventure Partners co-led the round, which included participation from existing shareholders Forbion Capital Partners, Credit Agricole Private Equity, LSP, BioGeneration Ventures, the Erasmus Biomedical Fund, Thuja Capital and VIB. Mike Sheffery of OrbiMed will join the company’s board.

SpineGuard has added $6.2 million in funding to expand its platform for enhanced spinal screw placement, which is designed to make spine surgery safer. Investors included Credit Agricole Private Equity, Innoven Partenaires, A Plus Finance, and Delta Partners. SpineGuard has offices in San Francisco and Paris.

German-based TrustYou, which provides online analysis of restaurant and hotel reviews, purchased Review Analyst and raised a $5 million first round of funding it announced on Tuesday. Paris-based Credit Agricole Private Equity led the financing. PRESS RELEASE TRUSTYOU SECURES $5 MILLION SERIES A ROUND AND ACQUIRES DALLAS-BASED REVIEW ANALYST BRINGING SOCIAL SENTIMENT SEARCH TO THE [...]

Forbion Capital Partners has led an 18 million euro ($25.3 million) Series A round for Belgium-based Amakem NV. Crédit Agricole Private Equity, Vesalius BioCapital, as well as the existing investors LRM, PMV and Life Sciences Research Partners also contributed to the round. Amakem will use the money to expand its ophthalmology drug development portfolio, the company said.

London-based Cellnovo, which develops a mobile diabetes management system, has raised £30 million ($48.4 million) in a Series B financing round led by Paris-based Edmond de Rothschild Investment Partners. Forbion Capital Partners, Auriga Partners, NBGI Ventures and Credit Agricole Private Equity also participated, as did Series A investors Advent Venture Partners, HealthCare Ventures and NESTA.